Literature DB >> 29486060

Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.

Vicente Soriano1, Ayalew Tefferi2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29486060     DOI: 10.1002/cncr.31291

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global health.

Authors:  Christina Psomas; Sabine Kinloch; Caroline Sabin; Vicente Soriano; Caroline Solas; Chloe Orkin; José Bernardino; Adrian Curran; Jean-Pierre Routy; Patricia Enel; Patrick Philibert; Alain Lafeuillade
Journal:  J Virus Erad       Date:  2018-07-01

2.  Effect of electrical stimulation for chemotherapy-induced nausea and vomiting in patients with liver cancer.

Authors:  Wei-Hong Li; Dong Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis.

Authors:  Michael J Zoratti; Ayesha Siddiqua; Rita E Morassut; Dena Zeraatkar; Roger Chou; Judith van Holten; Feng Xie; Eric Druyts
Journal:  EClinicalMedicine       Date:  2020-01-05

4.  Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019.

Authors:  Yuan Liu; Jinxin Zheng; Jialing Hao; Rang Rang Wang; Xueni Liu; Peng Gu; Hongwei Yu; Yang Yu; Chuanxing Wu; Baochi Ou; Zhihai Peng
Journal:  Cancer Med       Date:  2022-02-04       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.